Hualong Xunda Inc. builds digital twin factory and operation & maintenance center for China Resources Pharmaceutical Group via JIC digital twin platform to realize the transparency in the whole process of production and management. Simultaneously, it also achieves the simulation on equipments and techs on product lines, builds system for virtual training, production Kanban, lifecycle management, is with function of video monitoring, combines with related requirements for management and business to form digital twin factory which truely reflects the actual production of the group to reduce operation cost.
The Development Opportunity for Biomedicine Industry
Under the background of the pandemic, important development opportunity for biomedicine industry is coming. As one of high-tech industries that China mainly focuses on, biomedicine industry plays a more important role under the unprecedented attention from our country to it. It continuously tends to increase in sales and in product profits. In the future, with the deepening in aging of population of our country, people are attaching more importance to healthy life. In the meantime, with the increasing in demands of markets, biomedicine industry will keep getting attention from capital markets to usher its golden development period.
The Quality Specifications of GMP Medicines
With the global biomedicine industry to enter into the quick development period, the concentration rate of the biomedicine industry will also continue to increase, and the competition among enterprises will be fiercer. For enterprises, the key points they focus on most are how to keep innovation capacity on core techs, how to meet requirements for production compliance, to establish management rules for production quality of GMP medicines, to keep the stability of medicines' quality.